Cargando…

Disease-Modifying Therapy for Transthyretin Amyloidosis: Where to Start? Where to Stop?

Detalles Bibliográficos
Autor principal: Fine, Nowell M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299765/
https://www.ncbi.nlm.nih.gov/pubmed/34317122
http://dx.doi.org/10.1016/j.jaccas.2020.10.004
_version_ 1783726332423700480
author Fine, Nowell M.
author_facet Fine, Nowell M.
author_sort Fine, Nowell M.
collection PubMed
description
format Online
Article
Text
id pubmed-8299765
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-82997652021-07-26 Disease-Modifying Therapy for Transthyretin Amyloidosis: Where to Start? Where to Stop? Fine, Nowell M. JACC Case Rep Guest Editor's Page Elsevier 2020-11-18 /pmc/articles/PMC8299765/ /pubmed/34317122 http://dx.doi.org/10.1016/j.jaccas.2020.10.004 Text en © 2020 The Author https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Guest Editor's Page
Fine, Nowell M.
Disease-Modifying Therapy for Transthyretin Amyloidosis: Where to Start? Where to Stop?
title Disease-Modifying Therapy for Transthyretin Amyloidosis: Where to Start? Where to Stop?
title_full Disease-Modifying Therapy for Transthyretin Amyloidosis: Where to Start? Where to Stop?
title_fullStr Disease-Modifying Therapy for Transthyretin Amyloidosis: Where to Start? Where to Stop?
title_full_unstemmed Disease-Modifying Therapy for Transthyretin Amyloidosis: Where to Start? Where to Stop?
title_short Disease-Modifying Therapy for Transthyretin Amyloidosis: Where to Start? Where to Stop?
title_sort disease-modifying therapy for transthyretin amyloidosis: where to start? where to stop?
topic Guest Editor's Page
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299765/
https://www.ncbi.nlm.nih.gov/pubmed/34317122
http://dx.doi.org/10.1016/j.jaccas.2020.10.004
work_keys_str_mv AT finenowellm diseasemodifyingtherapyfortransthyretinamyloidosiswheretostartwheretostop